Mammary epithelial hyperplasias: Alterations related solely to proliferation? Rommel Rodríguez BurbanoJosé Barbieri NetoCacilda Casartelli Report Pages: 95 - 101
TP53 alterations in atypical ductal hyperplasia and ductal carcinomain situ of the breast Margaret ChitemerereTone Ikdahl AndersenJahn Marthin Nesland Report Pages: 103 - 109
The effects of cyclosporin A, tamoxifen, and medroxyprogesterone acetate on the enhancement of Adriamycin cytotoxicity in primary cultures of human breast epithelial cells Jerome A. ClaudioJoanne T. Emerman Report Pages: 111 - 122
Pre-morbid body-mass-index in breast cancer: Reversed effect on survival in hormone receptor negative patients Bjørn Ove MæhleSteinar Tretli Report Pages: 123 - 130
Improvement of quality control for steroid receptor measurements: Analysis of distributions in more than 40000 primary breast cancers Sylvie RomainFrédérique Spyratosbehalf of the French Study Group on Tissue and Molecular Biopathology Report Pages: 131 - 139
Influence of the extraction procedure on plasminogen activator inhibitor-2 (PAI-2) and urokinase receptor (uPAR) assays in breast cancer tissues Cécile Bouchet-BernetFrédérique SpyratosJean Oglobine Report Pages: 141 - 146
Selective growth of freshly isolated human breast epithelial cells cultured at low concentrations in the presence or absence of bone marrow cells Joanne T. EmermanJohn StinglConnie J. Eaves Report Pages: 147 - 159
Heterogeneity ofin vitro chemosensitivity in perioperative breast cancer cells to mitoxantroneversus doxorubicin evaluated by a microplate ATP bioluminescence assay Christian M. KurbacherIan A. CreeDieter Krebs Report Pages: 161 - 170
Immunosuppression by breast cancer associated p43-effect of immunomodulators Harald R. RosenChristoph AuschChaya Moroz Report Pages: 171 - 176
Time distribution of the recurrence risk for breast cancer patients undergoing mastectomy: Further support about the concept of tumor dormancy Romano DemicheliAntonello AbbattistaGianni Bonadonna Report Pages: 177 - 185
